MRI INTERVENTIONS, INC. (OTCMKTS:MRIC) Files An 8-K Regulation FD Disclosure
Item 7.01
| Regulation FD Disclosure |
On May 1, 2017, MRI Interventions, Inc. posted an updated
investor presentation to its website at
http://ir.stockpr.com/mriinterventions/investor-presentation. A
copy of the investor presentation is being furnished herewith as
Exhibit 99.1. The Company may use the investor presentation from
time-to-time in conversations with analysts, investors and
others.
The information in Item7.01 of this Form 8-K, as well as Exhibit
99.1 attached hereto, shall not be deemed filed for the purposes
of Section18 of the Exchange Act, nor shall it be deemed
incorporated by reference in any filing under the Securities Act,
or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
The information contained in Exhibit 99.1 is summary information
that is intended to be considered in the context of the Companys
filings with the Securities and Exchange Commission (SEC) and
other public announcements that the Company may make from
time-to-time, by press release or otherwise. The Company
undertakes no duty or obligation to publicly update or revise the
information contained in this investor presentation, although it
may do so from time-to-time as its management believes is
warranted. Any such updating may be made through the filing or
other reports or documents with the SEC, through press releases
or other public disclosure.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
The following exhibits are furnished herewith:
| Exhibit99.1 | Investor Presentation dated May 2017. |
About MRI INTERVENTIONS, INC. (OTCMKTS:MRIC)
MRI Interventions, Inc. is a medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. Its ClearPoint system is a neuro-navigation system designed for placing catheters and electrodes to treat a range of neurological diseases and conditions and for performing biopsies. Its ClearTrace system is designed to deliver catheter-based therapies to treat certain cardiac diseases. Both systems utilize intra-procedural MRI to guide the procedures. Its products and product candidates include ClearPoint Neuro Intervention System and The ClearTrace Cardiac Intervention System. MRI INTERVENTIONS, INC. (OTCMKTS:MRIC) Recent Trading Information
MRI INTERVENTIONS, INC. (OTCMKTS:MRIC) closed its last trading session 00.00 at 6.00 with 6,446 shares trading hands.
